Study Summary
This trial is testing a new treatment for diabetic foot ulcers, comparing it to standard care. The new treatment is a patch made from human placental umbilical cord tissue, applied every 4 weeks. The trial will measure how many ulcers are completely healed within 26 weeks.
- Non Healing Wounds
- Diabetic Foot Infection
- Non Healing Diabetic Foot Ulcer
Treatment Effectiveness
Effectiveness Progress
Study Objectives
0 Primary · 4 Secondary · Reporting Duration: by Week 50
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
TTAX01
1 of 1
Experimental Treatment
220 Total Participants · 1 Treatment Group
Primary Treatment: Standard Care · No Placebo Group · Phase 3
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 11 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Could you give me a breakdown of the patients who have signed up for this clinical trial?
"The sponsor, Tissue Tech Inc., needs to recruit 220 eligible patients from different locations in order to run the study. Some of these participating centres include Paley Orthopedic & Spine Institute and UCLA Olive View." - Anonymous Online Contributor
Has the FDA sanctioned Standard Care?
"Standard Care received a score of 3 on Power's safety scale." - Anonymous Online Contributor